Verona Pharma (VRP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

157.50p
   
  • Change Today:
      2.50p
  • 52 Week High: 197.50
  • 52 Week Low: 102.50
  • Currency: UK Pounds
  • Shares Issued: 105.02m
  • Volume: 24,935
  • Market Cap: 165.40m
  • RiskGrade: 280
  • Beta: 0.02

Verona Pharma Overview

Verona Pharma is developing first in class drugs to treat respiratory disease such as COPD asthma and chronic severe cough

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 2.1  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verona Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 n/a (2.81) (35.51)p n/a n/a n/a n/a 0.0%
31-Dec-14 n/a (3.76) (16.00)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.00) (1,855.00)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (5.97) (750.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (25.20) (23.40)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verona Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 n/a (36.13) (24.15)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (43.10) (28.77)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Verona Pharma Company Announcements

Verona Pharma Presented Clinical Data at ATS 201... 22-May-2018 07:03 GlobeNewswire EU
Verona Pharma plc : Miscellaneous 09-May-2018 13:30 GlobeNewswire EU
Verona Pharma plc Operational Update and Financi... 08-May-2018 07:00 GlobeNewswire EU

Latest Verona Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verona Pharma Market Data

Currency UK Pounds
Share Price 157.50p
Change Today 2.50p
% Change 1.61 %
52 Week High 197.50
52 Week Low 102.50
Volume 24,935
Shares Issued 105.02m
Market Cap 165.40m
Beta 0.02
RiskGrade 280

Verona Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.07% below the market average24.07% below the market average24.07% below the market average24.07% below the market average24.07% below the market average
23.81% above the sector average23.81% above the sector average23.81% above the sector average23.81% above the sector average23.81% above the sector average
Price Trend
36.49% above the market average36.49% above the market average36.49% above the market average36.49% above the market average36.49% above the market average
43.75% above the sector average43.75% above the sector average43.75% above the sector average43.75% above the sector average43.75% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 6
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Verona Pharma Dividends

No dividends found

Trades for 22-May-2018

Time Volume / Share Price
15:36 25,000 @ 155.00p
15:56 934 @ 160.00p
15:47 2,678 @ 160.00p
14:14 800 @ 150.30p
13:28 304 @ 164.00p

Verona Pharma Key Personnel

CEO Sven Jan-Anders Karlsson
CFO Piers Morgan

Top of Page